Diabetes Research & Development

“Intra-Cell" Diabetic & Metabolic Procedures & Equipment is a proven treatment initially for Type-1 and Type-2 diabetes that uniquely optimizes intra-cellular metabolism. Impaired intra-cellular energy causes insulin resistance, organ damage, and is present in most disease states including aging. Treatments uniquely reverses all measured diabetes complications as proven by the “diabetes gold-standard tests”. This is the only treatment to ever do so. Scientists agree that correcting intra-cellular metabolism is “a medical breakthrough.” Treatments have been uniformly successful in reversing each of these complications, even among the severely ill, something no other treatment has ever done,

Treatments: Patient treatments consist of one 3 hour treatment per week for 12 treatments. Treatments are provided in diabetic clinics and doctor’s offices until the patient is well enough for home use (usually 12 treatments). Training programs are complete and successful. Practitioners will adopt "Intra-Cell" Diabetic & Metabolic Procedures because they will, for the first time, be able to reverse diabetes complications.

Long term safety and efficacy data: Over 250,000 treatments have proven Intra-Cell" Diabetic & Metabolic Procedures & Equipment is safe with no adverse reaction or claims, and no diminished efficacy. This is because the treatments deliver what a normal pancreas delivers in a very special way that triggers the liver to restore carbohydrate metabolism. These levels of success are completely unlike any other reported corrective metabolic treatment.

"Intra-Cell" is now beginning the process of launching its distribution of its products, equipment, applications and procedures that will include opportunities to work together with existing medical practitioners and clinics as well as expansion of new clinics.

For more information on “Intra-Cell” please send an email request to Info@Intra-Cell.com 

We are also in the early stages of a stock offering and there will be an opportunity to invest in Intra-Cell as soon as our offering documents are completed.